BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 19230047)

  • 1. Serum biomarker tests are useful in delineating between patients with gastric atrophy and normal, healthy stomach.
    Iijima K; Abe Y; Kikuchi R; Koike T; Ohara S; Sipponen P; Shimosegawa T
    World J Gastroenterol; 2009 Feb; 15(7):853-9. PubMed ID: 19230047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serological Biomarker Panel in Diagnosis of Atrophic Gastritis and
    Koivurova OP; Koskela R; Blomster T; Ala-Rämi A; Lumme H; Kettunen O; Hukkanen J; Karttunen TJ; Mäkinen M; Ronkainen J; Syrjänen K
    Anticancer Res; 2021 Nov; 41(11):5527-5537. PubMed ID: 34732423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Serological diagnosis of atrophic gastritis with a combination of pepsinogen I and II, gastrin-17 and anti-Helicobacter pylori antibodies].
    Valle Muñoz J; Artaza Varasa T; López Pardo R; Rodríguez Merlo R; Pérez Grueso MJ; Martín Escobedo R; Alcántara Torres M; Cuena Boy R; Carrobles Jiménez JM
    Gastroenterol Hepatol; 2007 Dec; 30(10):567-71. PubMed ID: 18028850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels of amidated gastrin-17 and pepsinogen I in atrophic gastritis: an observational case-control study.
    Sipponen P; Ranta P; Helske T; Kääriäinen I; Mäki T; Linnala A; Suovaniemi O; Alanko A; Härkönen M
    Scand J Gastroenterol; 2002 Jul; 37(7):785-91. PubMed ID: 12190091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GastroPanel® test for non-invasive diagnosis of atrophic gastritis in patients with dyspepsia.
    Masci E; Pellicano R; Mangiavillano B; Luigiano C; Stelitano L; Morace C; Viale E; Freschi M; Locatelli M; Ieri R; Cavallaro A; Testoni S; Testoni PA
    Minerva Gastroenterol Dietol; 2014 Mar; 60(1):79-83. PubMed ID: 24632770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastric carcinoid tumors without autoimmune gastritis in Japan: a relationship with Helicobacter pylori infection.
    Sato Y; Iwafuchi M; Ueki J; Yoshimura A; Mochizuki T; Motoyama H; Sugimura K; Honma T; Narisawa R; Ichida T; Asakura H; Van Thiel DH
    Dig Dis Sci; 2002 Mar; 47(3):579-85. PubMed ID: 11911346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma ghrelin concentration correlates with the levels of serum pepsinogen I and pepsinogen I/II ratio--a possible novel and non-invasive marker for gastric atrophy.
    Suzuki H; Masaoka T; Hosoda H; Nomura S; Ohara T; Kangawa K; Ishii H; Hibi T
    Hepatogastroenterology; 2004; 51(59):1249-54. PubMed ID: 15362725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The correlation between histological gastritis staging- 'OLGA/OLGIM' and serum pepsinogen test in assessment of gastric atrophy/intestinal metaplasia in China.
    Wang X; Lu B; Meng L; Fan Y; Zhang S; Li M
    Scand J Gastroenterol; 2017 Aug; 52(8):822-827. PubMed ID: 28436254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-endoscopic diagnosis of atrophic gastritis with a blood test. Correlation between gastric histology and serum levels of gastrin-17 and pepsinogen I: a multicentre study.
    Väänänen H; Vauhkonen M; Helske T; Kääriäinen I; Rasmussen M; Tunturi-Hihnala H; Koskenpato J; Sotka M; Turunen M; Sandström R; Ristikankare M; Jussila A; Sipponen P
    Eur J Gastroenterol Hepatol; 2003 Aug; 15(8):885-91. PubMed ID: 12867799
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    MÄki M; SÖderstrÖm D; Paloheimo L; Hendolin P; Suovaniemi O; SyrjÄnen K
    Anticancer Res; 2020 Nov; 40(11):6387-6398. PubMed ID: 33109577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Potentialities of a serological method in diagnosis of atrophic gastritis].
    Pimenov SI; Makarenko EV
    Ter Arkh; 2008; 80(2):15-21. PubMed ID: 18372589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-endoscopic diagnosis of multifocal atrophic gastritis; efficacy of serum gastrin-17, pepsinogens and Helicobacter pylori antibodies.
    Hartleb M; Wandzel P; Waluga M; Matyszczyk B; Bołdys H; Romañczyk T
    Acta Gastroenterol Belg; 2004; 67(4):320-6. PubMed ID: 15727075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of H. pylori Infection and Atrophic Gastritis in a Population-based Screening with Serum Biomarker Panel (GastroPanel®) in St. Petersburg.
    Roman LD; Lukyanchuk R; Sablin OA; Araslanova EI; Eklund C; Hendolin P; Paloheimo L; Syrjänen K
    Anticancer Res; 2016 Aug; 36(8):4129-38. PubMed ID: 27466521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis of Helicobacter pylori-induced gastritis by serum pepsinogen levels.
    Kitamura Y; Yoshihara M; Ito M; Boda T; Matsuo T; Kotachi T; Tanaka S; Chayama K
    J Gastroenterol Hepatol; 2015 Oct; 30(10):1473-7. PubMed ID: 25974661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic values of serum levels of pepsinogens and gastrin-17 for screening gastritis and gastric cancer in a high risk area in northern Iran.
    Nejadi-Kelarijani F; Roshandel G; Semnani S; Ahmadi A; Faghani B; Besharat S; Akhavan-Tabib A; Amiriani T
    Asian Pac J Cancer Prev; 2014; 15(17):7433-6. PubMed ID: 25227854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pylori antibody titer.
    Yoshida T; Kato J; Inoue I; Yoshimura N; Deguchi H; Mukoubayashi C; Oka M; Watanabe M; Enomoto S; Niwa T; Maekita T; Iguchi M; Tamai H; Utsunomiya H; Yamamichi N; Fujishiro M; Iwane M; Takeshita T; Ushijima T; Ichinose M
    Int J Cancer; 2014 Mar; 134(6):1445-57. PubMed ID: 24009139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atrophic gastritis and Helicobacter pylori infection in outpatients referred for gastroscopy.
    Oksanen A; Sipponen P; Karttunen R; Miettinen A; Veijola L; Sarna S; Rautelin H
    Gut; 2000 Apr; 46(4):460-3. PubMed ID: 10716672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accuracy of GastroPanel for the diagnosis of atrophic gastritis.
    McNicholl AG; Forné M; Barrio J; De la Coba C; González B; Rivera R; Esteve M; Fernandez-Bañares F; Madrigal B; Gras-Miralles B; Perez-Aisa A; Viver-Pi-Sunyer JM; Bory F; Rosinach M; Loras C; Esteban C; Santolaria S; Gomollon F; Valle J; Gisbert JP;
    Eur J Gastroenterol Hepatol; 2014 Sep; 26(9):941-8. PubMed ID: 25014624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decrease of serum total ghrelin in extensive atrophic gastritis: comparison with pepsinogens in histological reference.
    Eun Bae S; Hoon Lee J; Soo Park Y; Ok Kim S; Young Choi J; Yong Ahn J; Hoon Kim D; Don Choi K; June Song H; Hyug Lee G; Choe J; Jin Jang S; Jung HY
    Scand J Gastroenterol; 2016; 51(2):137-44. PubMed ID: 26513345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The optimal serum pepsinogen cut-off value for predicting histologically confirmed atrophic gastritis.
    Kim EH; Kang H; Park CH; Choi HS; Jung DH; Chung H; Park JC; Shin SK; Lee SK; Lee YC
    Dig Liver Dis; 2015 Aug; 47(8):663-8. PubMed ID: 26077884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.